Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | SRC | P12931 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.46 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL502830 | 1.00 | DPP4 (0.52) | DPP4CYP2D6SRCLMNAMAPK1 | |
| SCHEMBL43672 | 1.00 | DPP4 (0.52) | DPP4CYP2D6SRCLMNAMAPK1 | |
| SCHEMBL29360215 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL4799572 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL7582981 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL9445669 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Methane SCHEMBL29238636 | 0.98 | DPP4 (0.50) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Carbamic Acid SCHEMBL29625257 | 0.96 | CYP2D6 (0.48) | DPP4CYP2D6SRCLMNAMAPK1 | |
| SCHEMBL7103757 | 0.88 | LMNA (0.45) | DPP4CYP2D6SRCLMNAMAPK1 | |
| Trifluoroacetic Acid SCHEMBL918979 | 0.88 | SLC1A3 (0.44) | DPP4CYP2D6SRCLMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3764 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114983-A1 | BIODEGRADABLE PIEZOELECTRIC NERVE-GUIDANCE CONDUIT FOR PROMOTING REGENERATION OF SEVERED NERVE AND METHOD FOR MANUFACTURING THE SAME | UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) | 2026-04-30 | — | — | US | claimed |
| US-20260096243-A1 | PREPARATION METHOD OF ELECTRODE GRID LINES, AND PHOTOVOLTAIC (PV) CELL | Beijing Zenithnano Technology Co., Ltd. (CN) | 2026-04-02 | — | — | US | claimed |
| US-12540161-B2 | Linkers | BICYCLETX LIMITED (GB) | 2026-02-03 | — | — | US | claimed |
| EP-4665887-A1 | PEPTIDE SELF-ASSEMBLY AS A STRATEGY FOR FACILE IMMOBILIZATION OF ENZYMES AND MICROORGANISMS ON ELECTRODES | Ramot at Tel-Aviv University Ltd. (IL) | 2025-12-24 | — | — | EP | claimed |
| US-20250369136-A1 | PEPTIDE SELF-ASSEMBLY AS A STRATEGY FOR FACILE IMMOBILIZATION OF ENZYMES AND MICROORGANISMS ON ELECTRODES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2025-12-04 | — | — | US | claimed |
| EP-4642489-A1 | CONJUGATE AND USES THEREOF | Full-Life Technologies HK Limited (HK) | 2025-11-05 | — | — | EP | claimed |
| US-20250332223-A1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIV MIAMI (US) | 2025-10-30 | — | — | US | claimed |
| US-20250332217-A1 | IMMUNE CHECKPOINT INHIBITOR COMBINATIONS | LYTIX BIOPHARMA AS (NO) | 2025-10-30 | — | — | US | claimed |
| EP-4637799-A1 | MEDICAL PRODUCTS CONTAINING AN AQUEOUS FORMULATION OF A PEPTIDE | Lytix Biopharma AS (NO) | 2025-10-29 | — | — | EP | claimed |
| EP-4637800-A1 | COMPOSITIONS COMPRISING AN ONCOLYTIC PEPTIDE AND CHITOSAN | Lytix Biopharma AS (NO) | 2025-10-29 | — | — | EP | claimed |
| US-5866679-A | AMINO ACID SEQUENCES THAT ARE RECOGNIZED AND PROTEOLYTICALLY CLEAVED BY FREE PROSTATE SPECIFIC ANTIGEN, CONJUGATES OF SUCH OLIGOPEPTIDES AND KNOWN CYTOTOXIC AGENTS | MERCK & CO., INC. (US) | 1999-02-02 | — | — | US | claimed |
| EP-0855910-A1 | CONJUGATES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | Merck & Co., Inc. (US) | 1998-08-05 | — | — | EP | claimed |
| EP-0853483-A1 | NOVEL PEPTIDES | Merck & Co., Inc. (US) | 1998-07-22 | — | — | EP | claimed |
| WO-1998025965-A2 | PEPTIDES AND COMPOUNDS THAT BIND TO THE THROMBOPOIETIN RECEPTOR | GLAXO GROUP LIMITED (GB) | 1998-06-18 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| EP-0771209-A2 | NOVEL PEPTIDES | Merck & Co., Inc. (a New Jersey corp.) (US) | 1997-05-07 | — | — | EP | claimed |
| WO-1997014416-A1 | CONJUGATES USEFUL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | claimed |
| WO-1997012624-A1 | NOVEL PEPTIDES | MERCK & CO., INC. (US) | 1997-04-10 | — | — | WO | claimed |
| WO-1996000503-A1 | NOVEL PEPTIDES | MERCK & CO., INC. (US) | 1996-01-11 | — | — | WO | claimed |
| EP-0331404-A2 | Method for producing tropane alkaloid | SEITAIKINOU RIYOU KAGAKUHIN SHINSEIZOUGIJUTSU KENKYU KUMIAI (JP) | 1989-09-06 | — | — | EP | claimed |